Bernat Queralt

Nombre:
Bernat Queralt
Firma: Bernat Queralt
Posición:
Metges Investigadors
Leer mas

Main researcher

Joan Figueras Felip 

 

Post-doctorate researchers

Mª José Ferri Iglesias

Rosa Peracaula

 

Español

Eres investigador?

Español

Si eres investigador si estás interesado en colaborar con cualquiera de nuestros grupos de investigación, rellena este formulario. Nos pondremos en contacto contigo lo antes posible. Gracias.

Dejanos tus datos

Leer mas
Leer mas

 

Main researcher

Joan Figueras Felip 

 

Post-doctorate researchers

MªJosé Ferri Iglesias

Rosa Peracaula

 

Pre-doctorate researchers

Julia Gil Garcia

Helena Salvador Roses

Inglés

Eres investigador?

Español

Si eres investigador si estás interesado en colaborar con cualquiera de nuestros grupos de investigación, rellena este formulario. Nos pondremos en contacto contigo lo antes posible. Gracias.

Dejanos tus datos

Leer mas

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

BACKGROUND: We previously reported a 35% overall response rate (ORR) with biweekly 5-fluorouracil (5-FU) continuous infusion (TTD [Spanish Cooperative Group for Digestive Tumour Therapy] schedule) plus irinotecan as first-line therapy in elderly patients with metastatic colorectal cancer (mCRC). The present study also was carried out in elderly patients to determine the efficacy and safety of the same 5-FU schedule plus oxaliplatin.

Undefined
Leer mas
Suscribirse a Bernat Queralt